High-affinity antibodies (Abs) are the most important effector molecules for host defense against bacterial and virial infections. High-affinity Abs are generated during the germinal center (GC) reaction where B cells undergo enormous expansion, accompanied by Ig gene somatic hypermutation (SHM) and class switch recombination. SHM alters the Ab specificity of GCB and those with high affinity for the foreign antigen are selected to differentiate into antibody-secreting plasma cells or memory B cells. SHM also generates low affinity and auto-reactive GCB cells, the later must be eliminated by apoptosis to avoid the production of autoantibodies and the development of autoimmune diseases. We have recently found that the transcription elongation-associated factor EAF2 is highly expressed in GCB and specifically induces their apoptosis. Absence of EAF2 results in autoantibody production and elevated susceptibility to autoimmune diseases, suggesting that EAF2 is involved in the elimination of autoreactive GCB. In the current project, we aim to prove that EAF2 indeed mediates the apoptosis of GCB using both in vivo and in vitro experiments. In addition, we will elucidate the functional interactions between EAF2 and BCL-2 family in regulating apoptosis. Furthermore, we hope to elucidate the gene transcription network mediated by EAF2 in GCB cells. Our results will provide important insights in understanding the mechanism of autoantibody production and autoimmune diseases.
高亲和力抗体是感染防御的最重要效应分子。B细胞在抗原刺激和T细胞辅助下快速分裂形成生发中心(Germinal center, GC),通过体细胞超突变(SHM)产生高亲和力GCB。SHM同时还会产生自身反应性GCB,机体通过诱导凋亡将其清除,从而防止自身抗体的产生和自身免疫性疾病。我们课题组首次发现转录延伸因子EAF2在GCB高表达,并特异性调控GCB的凋亡,EAF2缺失会导致自身抗体的产生及自身免疫疾病的发生,提示EAF2可能在清除自身反应性GCB中发挥作用。围绕这一现象,为阐明EAF2在自身反应性GCB凋亡中的作用及机制,我们拟做以下研究: 1)在体外及体内实验中分别探索EAF2在介导自身反应性GCB凋亡中的作用。2)明确EAF2与BCL-2家族分子之间的功能性的相互作用关系。3)解明EAF2在GCB的基因调控网络中发挥的作用。4)探索EAF2在抑制B淋巴瘤发生中的作用和机制。
本课题组首次发现转录延伸因子EAF2在生发中心B细胞(GCB)高表达,在前期研究中发现EAF2促进GCB的凋亡,揭示了EAF2缺陷小鼠在T依赖性抗原免疫后形成的生发中心变大,随着周龄的增长自发性地产生自身抗体,以及易发II型胶原蛋白诱导的自身免疫性关节炎。本项目聚焦EAF2在清除自身反应性GCB细胞中的作用和机制,获得以下主要成果:1)明确了EAF2促进自身反应性GCB的凋亡;2)揭示了BCL-2能够部分抑制EAF2诱导的B细胞凋亡;3)发现EAF2调控Wnt/β-catenin,TGFβ以及RAS-BRAF-ERK等通路;4)EAF2缺陷可能通过促进B细胞异常增殖诱发小鼠弥漫型大B细胞淋巴瘤。本项目的研究结果揭示了清除自身反应性GCB的新分子,为自身抗体产生和自身免疫性疾病的发生机制提供了新思路。
{{i.achievement_title}}
数据更新时间:2023-05-31
The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects
视网膜母细胞瘤的治疗研究进展
Bousangine A, a novel C-17-nor aspidosperma-type monoterpenoid indole alkaloid from Bousigonia angustifolia
结核性胸膜炎分子及生化免疫学诊断研究进展
PI3K-AKT-mTOR通路对骨肉瘤细胞顺铂耐药性的影响及其机制
受体编辑在天然自身反应性B细胞发育耐受中的作用和机制研究
PHF14在生发中心B细胞反应中的作用及机制研究
ZBTB24在生发中心B细胞中的作用及其机制研究
Stch调控生发中心B细胞反应和抗体产生的分子与细胞机制